Global /South Korea /Healthcare /Medical Care Facilities /221800

U2Bio Co., Ltd.

221800

• KRX: 221800 • Delayed

18,050KRW -7.4%

11.78 USD

As of 5 June 2026, U2Bio Co., Ltd. has a market cap of $187.62M USD, ranking #21519 globally and #858 in South Korea. It ranks #1929 in the Healthcare sector, and #225 in the Medical Care Facilities industry.

Global Rank

21519

Country Rank

858

Sector Rank

1929

Industry Rank

225

Key Stats

Market Cap

$187.62MUSD

287.58B KRW

Enterprise Value

$167.18MUSD

256.26B KRW

Revenue (TTM)

$16.7MUSD

25.59B KRW

EBITDA (TTM)

-$885.3KUSD

-1.36B KRW

Net Income (TTM)

-$1.07MUSD

-1.64B KRW

EBITDA Margin

-5.3%

Profit Margin

-6.4%

PS Ratio

11.2

PB Ratio

6.8

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Jin-Tae Kim open_in_new

Founded

2009

Website

u2bio.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-7.4%	25%	4.3%	299%	477%	397%	504%	176%	653%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	221800 유투바이오 ISIN: KR7221800006 Shares Out.: Shares Outstanding: 16.319M¹ Shares Float: 6.43M² TV: TradingView: KRX: 221800 SA: Stock Analysis: KRX: 221800 YF: Yahoo Finance: 221800.KS GF: Google Finance: KRX: 221800 BA: Barron's: 221800 MS: Morningstar: XKRX: 221800	18,050 KRW	TV: TradingView: KRX: 221800 SA: Stock Analysis: KRX: 221800 YF: Yahoo Finance: 221800.KS GF: Google Finance: KRX: 221800 BA: Barron's: 221800 MS: Morningstar: XKRX: 221800

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About U2Bio Co., Ltd.

U2Bio Co., Ltd. provides healthcare services in South Korea. The company also offers specimen testing services; digital healthcare services related to testing and health examinations; and bio-technology platforms. The company was founded in 2009 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Medical Care Facilities (South Korea)

Name	Market Cap (USD) diff.	PE	Country
HK inno.N Corp. KRX: 195940	$1.0B 1.54T KRW 435%	37.4	South Korea
JS Link, Inc. KRX: 127120	$925.02M 1.42T KRW 393%	-	South Korea
Penetrium Bioscience Inc. KRX: 187660	$432.3M 662.64B KRW 130%	-	South Korea
Genomictree Inc. KRX: 228760	$274.11M 420.17B KRW 46%	-	South Korea
HansBiomed Corp. KRX: 042520	$273.54M 419.28B KRW 46%	-	South Korea
GC Genome Corp. KRX: 340450	$133.93M 205.29B KRW -29%	46.9	South Korea

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 124K%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 51K%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.68B 22.97B EUR 14K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.58B 22.02B EUR 14K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 12K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 11K%	24.6	United States

chevron_leftBack